These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10521654)

  • 1. Ribozymes and the anti-gene therapy: how a catalytic RNA can be used to inhibit gene function.
    Muotri AR; da Veiga Pereira L; dos Reis Vasques L; Menck CF
    Gene; 1999 Sep; 237(2):303-10. PubMed ID: 10521654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-gene therapy: the use of ribozymes to inhibit gene function.
    Couture LA; Stinchcomb DT
    Trends Genet; 1996 Dec; 12(12):510-5. PubMed ID: 9257533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic potential of ribozymes.
    James HA; Gibson I
    Blood; 1998 Jan; 91(2):371-82. PubMed ID: 9427689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribozymes: recent advances in the development of RNA tools.
    Puerta-Fernández E; Romero-López C; Barroso-delJesus A; Berzal-Herranz A
    FEMS Microbiol Rev; 2003 Apr; 27(1):75-97. PubMed ID: 12697343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribozymes as antiviral agents.
    Bartolomé J; Castillo I; Carreño V
    Minerva Med; 2004 Feb; 95(1):11-24. PubMed ID: 15041923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribozyme: a clinical tool.
    Khan AU
    Clin Chim Acta; 2006 May; 367(1-2):20-7. PubMed ID: 16426595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribozymes: biology, biochemistry, and implications for clinical medicine.
    Kiehntopf M; Esquivel EL; Brach MA; Herrmann F
    J Mol Med (Berl); 1995 Feb; 73(2):65-71. PubMed ID: 7627631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of ribozymes in haematological disorders.
    James HA
    Expert Opin Investig Drugs; 2000 May; 9(5):1009-20. PubMed ID: 11060723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribozymes as therapeutic tools for genetic disease.
    Phylactou LA; Kilpatrick MW; Wood MJ
    Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and validation of therapeutic hammerhead ribozymes for autosomal dominant diseases.
    Fritz JJ; Gorbatyuk M; Lewin AS; Hauswirth WW
    Methods Mol Biol; 2004; 252():221-36. PubMed ID: 15017052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-expressed RNA as a therapeutic: issues to consider, using ribozymes and small hairpin RNA as specific examples.
    Fanning GC; Symonds G
    Handb Exp Pharmacol; 2006; (173):289-303. PubMed ID: 16594621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.
    Rossi JJ; Elkins D; Taylor N; Zaia J; Sullivan S; Deshler JO
    Antisense Res Dev; 1991; 1(3):285-8. PubMed ID: 1821650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems.
    Rossi JJ; Elkins D; Zaia JA; Sullivan S
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):183-9. PubMed ID: 1540406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of preformed hammerhead ribozymes in the gene therapy of cancer (review).
    Sioud M
    Int J Mol Med; 1999 Apr; 3(4):381-4. PubMed ID: 10085409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribozymes: from mechanistic studies to applications in vivo.
    Ohkawa J; Koguma T; Kohda T; Taira K
    J Biochem; 1995 Aug; 118(2):251-8. PubMed ID: 8543555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection and evolution of RNA: applications for catalytic RNA, molecular recognition, and drug discovery.
    Burke JM; Berzal-Herranz A
    FASEB J; 1993 Jan; 7(1):106-12. PubMed ID: 8422956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribozymes: structure, characteristics and use as potential antiviral agents.
    Bartolomé J; Madejón A; Carreño V
    J Hepatol; 1995; 22(1 Suppl):57-64. PubMed ID: 7602079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of ribozymes to HIV infection.
    Rossi JJ
    Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered ribozymes as molecular tools for site-specific alteration of RNA sequence.
    Müller S
    Chembiochem; 2003 Oct; 4(10):991-7. PubMed ID: 14523916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.